Ileal interposition surgery-induced improvement of hyperglycemia and insulin resistance in Goto-Kakizaki rats by upregulation of TCF7L2 expression

Sun,Xu; Song,Maomin; Bai,Rixing; Cheng,Shi; Xing,Ying; Yuan,Huisheng; Wang,Pilin; Zhou,Lisa

doi:10.3892/etm.2013.998

Ileal interposition surgery-induced improvement of hyperglycemia and insulin resistance in Goto-Kakizaki rats by upregulation of TCF7L2 expression

Authors:
- Xu Sun
- Maomin Song
- Rixing Bai
- Shi Cheng
- Ying Xing
- Huisheng Yuan
- Pilin Wang
- Lisa Zhou
View Affiliations

Affiliations: Department of General Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Biology and Computer Science, Columbia College, Columbia University in the City of New York, New York, NY 10027, USA
Published online on: March 12, 2013 https://doi.org/10.3892/etm.2013.998
Pages: 1511-1515

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the effects of ileal interposition (IT) on glucose and insulin resistance (IR) in type 2 diabetic mellitus (T2DM), and the role of T-cell factor 7-like 2 (TCF7L2), formerly known as TCF4, in the downregulation of hyperglycemia following IT. Goto-Kakizaki (GK) rats subjected to IT surgery (GK-IT group), GK rats subjected to sham surgery (GK-Sham group) and Wistar (WS) rats subjected to sham surgery (WS-Sham group) were investigated in this study. Fasting plasma glucose, body weight, food intake per 1 kg body weight, insulin and a homeostasis model assessment of insulin resistance (HOMA-IR) were measured pre- and post-surgery. The rats were euthanized 28 days post-surgery and the pancreas of each rat was dissected. The expression levels of TCF7L2 mRNA and protein were analyzed by quantitative RT-PCR and western blotting, respectively. Our results revealed that IT improved both fasting plasma glucose levels and IR in GK rats by upregulating the expression of the TCF7L2 protein. IT provides a valuable therapeutic option for patients with T2DM. Upregulation of TCF7L2 protein expression may be a possible mechanism underlying the improvement of T2DM following IT.

View Figures

View References

1.	King H, Aubert RE and Herman WH: Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 21:1414–1431. 1998.
2.	Stumvoll M, Goldstein BJ and van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 365:1333–1346. 2005. View Article : Google Scholar : PubMed/NCBI
3.	Zimmet P, Alberti KG and Shaw J: Global and societal implications of the diabetes epidemic. Nature. 414:782–787. 2001. View Article : Google Scholar : PubMed/NCBI
4.	Schauer PR, Burguera B, Ikramuddin S, et al: Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 238:467–484. 2003.PubMed/NCBI
5.	Rubino F, Gagner M, Gentileschi P, et al: The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 240:236–242. 2004. View Article : Google Scholar : PubMed/NCBI
6.	Gill RS, Sharma AM, Al-Adra DP, Birch DW and Karmali S: The impact of bariatric surgery in patients with type-2 diabetes mellitus. Curr Diabetes Rev. 7:185–189. 2011. View Article : Google Scholar : PubMed/NCBI
7.	Baggio LL and Drucker DJ: Biology of incretins: GLP-1 and GIP. Gastroenterology. 132:2131–2157. 2007. View Article : Google Scholar : PubMed/NCBI
8.	Chen DC, Stern JS and Atkinson RL: Effects of ileal transposition on food intake, dietary preference, and weight gain in Zucker obese rats. Am J Physiol. 258:R269–273. 1990.PubMed/NCBI
9.	Rulifson IC, Karnik SK, Heiser PW, et al: Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci USA. 104:6247–6252. 2007. View Article : Google Scholar : PubMed/NCBI
10.	Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH and Maedler K: Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet. 18:2388–2399. 2009. View Article : Google Scholar
11.	Culnan DM, Albaugh V, Sun M, Lynch CJ, Lang CH and Cooney RN: Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat. Am J Physiol Gastrointest Liver Physiol. 299:G751–G760. 2010. View Article : Google Scholar : PubMed/NCBI
12.	Strader AD, Vahl TP, Jandacek RJ, Woods SC, D’Alessio DA and Seeley RJ: Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab. 288:E447–E453. 2005. View Article : Google Scholar : PubMed/NCBI
13.	Wang TT, Hu SY, Gao HD, et al: Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg. 247:968–975. 2008. View Article : Google Scholar : PubMed/NCBI
14.	Chelikani PK, Shah IH, Taqi E, Sigalet DL and Koopmans HH: Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats. Obes Surg. 20:1281–1288. 2010. View Article : Google Scholar : PubMed/NCBI
15.	Patriti A, Aisa MC, Annetti C, et al: How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-Kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery. 142:74–85. 2007. View Article : Google Scholar : PubMed/NCBI
16.	Cummings BP, Strader AD, Stanhope KL, et al: Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology. 138:2437–2446. 2010. View Article : Google Scholar : PubMed/NCBI
17.	Welters HJ and Kulkarni RN: Wnt signaling: relevance to beta-cell biology and diabetes. Trends Endocrinol Metab. 19:349–355. 2008. View Article : Google Scholar : PubMed/NCBI
18.	Angus-Hill ML, Elbert KM, Hidalgo J and Capecchi MR: T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc Natl Acad Sci USA. 108:4914–4919. 2011. View Article : Google Scholar : PubMed/NCBI
19.	Jin T and Liu L: The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol. 22:2383–2392. 2008. View Article : Google Scholar : PubMed/NCBI
20.	Grant SF, Thorleifsson G, Reynisdottir I, et al: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 38:320–323. 2006. View Article : Google Scholar : PubMed/NCBI
21.	Lyssenko V, Lupi R, Marchetti P, et al: Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 117:2155–2163. 2007. View Article : Google Scholar : PubMed/NCBI
22.	Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J and Maedler K: Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes. 57:645–653. 2008. View Article : Google Scholar : PubMed/NCBI
23.	da Silva Xavier G, Mondragon A, Sun G, Chen L, McGinty JA, French PM and Rutter GA: Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabetologia. 55:2667–2676. 2012.PubMed/NCBI